Literature DB >> 18801211

Assessment and management of chronic pain in individuals seeking treatment for opioid dependence disorder.

Michael R Clark1, Kenneth B Stoller, Robert K Brooner.   

Abstract

OBJECTIVE: To review the problem of chronic pain in patients with substance use disorders, focusing on the prevalence of chronic pain in patients with substance dependence disorders, especially prescription opioid dependence, associated comorbidities, and the impact on drug abuse treatment response.
METHOD: We identified relevant articles using PubMed from 1987 to 2008. Additional articles were obtained from the reference lists of key reviews of relevant topics. Studies were included if they investigated the relation between chronic pain and substance use disorders. Of particular interest were articles that proposed integrated treatment for both problems.
RESULTS: The high prevalence of chronic pain syndromes was only recently explored in patients seeking treatment for drug abuse. The presence of chronic pain increases the risk of poor response to substance abuse treatment and an increased likelihood of multiple comorbidities that further add to the negative impact experienced by patients with substance dependence disorders. Substance abuse treatment programs offering integrated medical and psychiatric care for these comorbidities improve outcomes, with stepped care approaches offering the best treatment by tailoring the level of care to the individual patient's needs.
CONCLUSIONS: Substance abuse treatment programs should expand their services to address the comorbidities likely to pose barriers to successful drug rehabilitation. Given the high prevalence and negative impact of chronic pain, new pain management services should be integrated within the drug treatment program and adapted as patients demonstrate the need for more intensive treatment. If applied to the problem of chronic pain, a model substance abuse treatment program of integrated stepped care would improve outcomes for patients with both devastating disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18801211     DOI: 10.1177/070674370805300804

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  16 in total

1.  Neurophysiological mechanisms in acceptance and commitment therapy in opioid-addicted patients with chronic pain.

Authors:  Rachel F Smallwood; Jennifer S Potter; Donald A Robin
Journal:  Psychiatry Res Neuroimaging       Date:  2016-03-08       Impact factor: 2.376

Review 2.  Buprenorphine Treatment for Adolescents and Young Adults With Opioid Use Disorders: A Narrative Review.

Authors:  Jacob T Borodovsky; Sharon Levy; Marc Fishman; Lisa A Marsch
Journal:  J Addict Med       Date:  2018 May/Jun       Impact factor: 3.702

3.  Development and Preliminary Evaluation of an Integrated Cognitive-Behavior Treatment for Chronic Pain and Substance Use Disorder in Patients with the Hepatitis C Virus.

Authors:  Benjamin J Morasco; David W Greaves; Travis I Lovejoy; Dennis C Turk; Steven K Dobscha; Peter Hauser
Journal:  Pain Med       Date:  2016-06-27       Impact factor: 3.750

4.  Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patients.

Authors:  Declan T Barry; Mark Beitel; Brian Garnet; Dipa Joshi; Andrew Rosenblum; Richard S Schottenfeld
Journal:  J Clin Psychiatry       Date:  2009-07-14       Impact factor: 4.384

5.  Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study.

Authors:  Amit Chakrabarti; George E Woody; Margaret L Griffin; Geetha Subramaniam; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2009-11-30       Impact factor: 4.492

6.  Characteristics of methadone maintenance treatment patients prescribed opioid analgesics.

Authors:  Matthew C Glenn; Nancy L Sohler; Joanna L Starrels; Jeronimo Maradiaga; John J Jost; Julia H Arnsten; Chinazo O Cunningham
Journal:  Subst Abus       Date:  2016-01-05       Impact factor: 3.716

7.  Using enhanced and integrated services to improve response to standard methadone treatment: changing the clinical infrastructure of treatment networks.

Authors:  Karin Neufeld; Michael Kidorf; Van King; Ken Stoller; Michael Clark; Jessica Peirce; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2009-08-29

8.  Allopathic, complementary, and alternative medical treatment utilization for pain among methadone-maintained patients.

Authors:  Declan T Barry; Mark Beitel; Christopher J Cutter; Brian Garnet; Dipa Joshi; Richard S Schottenfeld; Bruce J Rounsaville
Journal:  Am J Addict       Date:  2009 Sep-Oct

Review 9.  Psychiatric issues in chronic pain.

Authors:  Michael R Clark
Journal:  Curr Psychiatry Rep       Date:  2009-06       Impact factor: 5.285

10.  Gabapentin improves cold-pressor pain responses in methadone-maintained patients.

Authors:  Peggy Compton; Priscilla Kehoe; Karabi Sinha; Matt A Torrington; Walter Ling
Journal:  Drug Alcohol Depend       Date:  2010-02-16       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.